Menopausal Hot Flashes Treatment Market

Q: What will be the CAGR of the global menopausal hot flashes treatment industry during the forecast period?

The CAGR is anticipated to be 4.8% from 2025 to 2035 Read More

Menopausal Hot Flashes Treatment Market (Treatment Type: Hormonal Treatment and Non-Hormonal Treatment; Drug Type: Branded and Generic; and Route of Administration: Oral, Transdermal, Vaginal and Parenteral) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

Menopausal Hot Flashes Treatment Market Outlook 2035

The global menopausal hot flashes treatment market size was valued at US$ 6.9 billion in 2024 and is projected to reach US$ 11.5 billion by 2035, expanding at a CAGR of 4.8% from 2025 to 2035. The market growth is driven by increasing global population of aging women, growing awareness about menopause and its symptoms and development of both hormonal and non-hormonal therapies.

Market Size & Highlights

The menopausal hot flashes treatment market reached US$ 6.9 Billion in 2024.
The market is expected to climb to US$ 11.5 Billion by 2035.
The industry is anticipated to expand at a CAGR of 4.8% from 2025 to 2035.
Top companies in the market include Bayer AG, Pfizer Inc., and Merck & Co., Inc.
North America dominated the market in 2024, holding the largest revenue share of 43.5%.
By treatment type, the hormonal treatment segment held the major market share of 57.9% in 2024.

Menopausal Hot Flashes Treatment Market By Revenue

Analysts’ Viewpoint regarding Menopausal Hot Flashes Treatment Market

The menopausal hot flashes treatment industry is witnessing steadiness fueled by the rising incidence of lifestyle disorders such as obesity, hypertension, and diabetes, which aggravate vasomotor symptoms of menopause. These lifestyle disorders intensify the frequency of hot flashes, hence increasing the demand for therapeutic solutions.

Non-hormonal and hormonal therapies are used by healthcare professionals for these complications as the clinical data shows the association between metabolic diseases and menopausal discomfort. As patient population grows more complex, this medical interplay is becoming a significant catalyst for treatment uptake.

Another important factor that underlines market growth is a patient-centered approach to therapy and personalized treatment. The diverse symptoms of menopausal experiences has resulted in the need for treatment that can be personalized to symptom profile, severity, and contraindication. Non-hormonal pharmacological therapy is being developed such as selective serotonin reuptake inhibitors and NK3 receptor antagonists that allow for an increase in therapeutic options for women who suffer from medical risks and are forced to discontinue hormone replacement therapy.

The competitive landscape characterization includes ongoing clinical studies, innovation in product pipelines, and collaborations that promote next generation of menopausal hot flashes’ therapies. Firms are investing into late-stage clinical trials to obtain approvals from regulatory bodies for novel non-hormonal drugs which are characterized by better safety profile.

Menopausal Hot Flashes Treatment Market Introduction

The treatment for menopausal hot flashes refers to a range of medical and supplementary interventions designed for reducing the disturbance caused by hot flashes at the time of transition to menopause. Hot flashes are sudden sensations of heat, usually accompanied by flushing, sweating, and palpitations, which interrupt mood, sleep, and quality-of-life. The treatments aim to control such vasomotor symptoms through non-hormonal and hormonal drugs, or other means depending on a woman's thorough health profile, treatment choices, and risk factors.

One of the most established treatment modalities for hot flashes is the hormone replacement therapy (HRT), especially for women witnessing moderate to severe hot flushes. HRT, through estrogen alone, or in combination with progesterone, does normalize temperature regulation by hypothalamus, thereby lowering the hot flashes’ intensity.

For women ineligible for hormone-based therapy, non-hormonal treatments offer a reliable and clinically effective alternative. The doctors prefer using serotonin-norepinephrine reuptake inhibitors (SNRIs), selective serotonin reuptake inhibitors (SSRIs), and some anticonvulsants controlling various symptoms. This alleviates the symptoms and makes provisions for increased safety to patients who have contraindications to hormonal therapy, thereby enabling increased treatment access.

Lifestyle and complementary approaches are also significant in alleviation of menopausal hot flashes. Techniques include maintenance of a cold environment, practicing relaxation methods, incorporation of regular exercise, and nutritional supplements for overcoming the sufferings. Besides, the latest therapeutic inventions such as herbal remedies and neurokinin receptor antagonists are emerging as promising solutions, as they offer multiple options for long-term symptom management.

Attribute	Detail
Menopausal Hot Flashes Treatment Market Drivers	Increased Awareness of Menopause Symptoms Rising Aging Female Population

Increased Awareness of Menopause Symptoms to Pitch the Menopausal Hot Flashes Treatment Market Share

Growing awareness of menopause symptoms is one of the drivers to the menopausal hot flashes treatment Industry. Due to widespread educational campaigns and expanded discussions across digital and mainstream media platforms, more number of women are aware of the menopausal symptoms. Such enhanced awareness is created through internet-activated health information, interventions in public health, and media debate, which reduce the stigma pertaining to menopause and persuade women to discuss their symptoms out in the open.

Healthcare providers play an important role in raising awareness by apprising patients about non-hormonal and hormonal therapy options for managing menopausal symptoms. This change of attitude has made patients more willing to accept interventions.

Additionally, the advent of telemedicine and digital health platforms has facilitated the accessibility of menopause information. Wearable devices allow women to track sleep disturbances, hot flash episodes, and mood changes, thereby providing objective data for clinicians for recommending tailored treatments.

Telemedicine platforms and digital consultations enable convenient access to therapy, particularly in remote areas or for women with busy lifestyles. Consequently, the pharmaceutical industry, along with the healthcare providers, are witnessing an increased demand for not only the revival of the standard therapies but also for novel treatment options. Awareness is a major factor in promoting market growth and it also plays an essential role in prompting companies in investing in research and development related to safer, more effective treatment modalities. This cycle of education, demand, and innovation keeps propelling the menopausal hot flashes treatment market, across the globe.

Increased Aging Female Population is Influencing the Menopausal Hot Flashes Treatment Market Share

Increased number of women approaching menopause is one of the primary factors influencing the menopausal hot flashes treatment industry. As women enter the age ranging between 45 to 55 years, they witness menopause, which is followed by vasomotor symptoms of night sweats and hot flashes. Due to the increased life expectancy across the globe, women survive longer after menopause, thereby raising the patient population for effective treatment.

The population shift is the key in developed economies such as North America and Europe, where awareness and access of healthcare are enhanced. Even emerging economies in Latin America and Asia Pacific are experiencing high population growth amongst the elderly women’s segment, which adds to the rising demand for therapies.

Pharmaceutical companies are reacting to the increased demand by focusing on development of new treatments that include neurokinin-3 receptor antagonists and natural supplements to overcome the safety concerns that are usually linked with traditional HRT.

The demography of aging female population is significantly fueling the market for menopause-related symptoms and has a substantial impact on treatment preferences, leading to the development of new treatments and the growth of revenues in the menopausal hot flashes treatment market.

Hormonal Treatment Leading Global Menopausal Hot Flashes Treatment Market

Menopausal Hot Flashes Treatment Market By Treatment Type

Hormonal treatment captures majority of the market share in the menopausal hot flashes treatment industry towing to its proven efficacy and existence of established treatment guidelines. Hormonal therapies are highly effective in the alleviation of menopausal symptoms of hot flashes, thereby making them a preferred choice among many women. Additionally, clinical guidelines endorse hormonal treatment as a first-line option, thereby reinforcing its acceptance and credibility among healthcare providers.

Moreover, hormonal therapies have always been supported by robust clinical evidence for their safety and efficiency when proper administration is followed. Drug manufacturers still make progress in the development of their products with the introduction of transdermal and low-dose formulations aimed at reducing the risk of side-effects and improving patient compliance.

Regional Outlook of Menopausal Hot Flashes Treatment Market

Menopausal Hot Flashes Treatment Market By Region

Attribute	Detail
Leading Region	North America

As per the latest menopausal hot flashes treatment market analysis, North America dominated the market in 2024, capturing a market share of 43.5%. One of the reasons is that the region has a well-established healthcare system and high health awareness related to menopause. Furthermore, women in the region have an improved access to medical check-ups, diagnostic tests, and treatment with prescriptions like HRT and non-hormonal therapies.

Additionally, the region has a substantial female population of old age, robust pharmaceutical R&D activities, and favorable regulatory conditions that encourage the approval and availability of new drugs. These positive factors, along with consumer awareness at a high level, indicate that North America accounts for the largest share of the global menopausal hot flashes treatment market.

Analysis of Key Players in Menopausal Hot Flashes Treatment Market

The key market strategies adopted by companies operating in the menopausal hot flashes treatment industry include the introduction of new hormone and non-hormone therapies, availability of products through distribution channels and partnerships, allocation of resources for research related to novel treatments, and promotion of awareness through education about menopause management.

Bayer AG, Astellas Pharma Inc., Pfizer Inc., Novartis AG, Merck & Co., Inc., Eli Lilly and Company, Hisamitsu Pharmaceutical Co., Inc., TherapeuticsMD, Inc., Lupin, GSK plc., Theramex, Fervent Pharmaceuticals Inc., AbbVie Inc., Gennev and Teva Pharmaceutical Industries Ltd. are some of the leading players operating in the global menopausal hot flashes treatment market.

Each of these players has been profiled in the menopausal hot flashes treatment market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Key Developments in Menopausal Hot Flashes Treatment Market

In December 2024, Astellas Pharma Canada, Inc. announced that Health Canada had approved its VEOZAH (fezolinetant film-coated tablets), the first non-hormonal treatment meant for the treatment of moderate-to-severe menopausal-related vasomotor symptoms (VMS).
In August 2024, Bayer announced that a New Drug Application (NDA) for investigational drug elinzanetant was submitted to the U.S. Food and Drug Administration (FDA) for treating moderate-to-severe vasomotor symptoms (VMS, or hot flashes) of menopause. The filing came in the wake of conducive outcomes in the Phase III OASIS 1, 2 and 3 studies.

Menopausal Hot Flashes Treatment Market Snapshot

Attribute	Detail
Size in 2024	US$ 6.9 Bn
Forecast Value in 2035	US$ 11.5 Bn
CAGR	4.8%
Forecast Period	2025-2035
Historical Data Available for	2020-2023
Quantitative Units	US$ Bn
Menopausal Hot Flashes Treatment Market Analysis	It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis.
Competition Landscape	Competition Matrix Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format	Electronic (PDF) + Excel
Segmentation	Treatment Type Hormonal Treatment Estrogen Progesterone Estrogen-progesterone Combination Non-Hormonal Treatment NK-3 Receptor Antagonists Selective Serotonin Reuptake Inhibitors (SSRIs) Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) Gabapentinoids Others (alpha-2 adrenergic agonist, etc.) Drug Type Branded Generic Route of Administration Oral Transdermal Vaginal Parenteral Menopause Stage Pre-menopause Post-menopause Distribution Channel Hospital Pharmacies Retail Pharmacies Online Pharmacies
Regions Covered	North America Europe Asia Pacific Latin America Middle East & Africa
Countries Covered	U.S. Canada Germany U.K. France Italy Spain The Netherlands China Australia India Japan South Korea ASEAN Brazil Mexico Argentina GCC Countries South Africa
Companies Profiled	Bayer AG Astellas Pharma Inc. Pfizer Inc. Novartis AG Merck & Co., Inc. Eli Lilly and Company Hisamitsu Pharmaceutical Co., Inc. TherapeuticsMD, Inc. Lupin GSK plc. Theramex Fervent Pharmaceuticals Inc. AbbVie Inc. Gennev Teva Pharmaceutical Industries Ltd.
Customization Scope	Available upon request
Pricing	Available upon request

Frequently Asked Questions

How big was the global menopausal hot flashes treatment market in 2024?

The global menopausal hot flashes treatment market was valued at US$ 6.9 Bn in 2024

How big will the global menopausal hot flashes treatment industry be in 2035?

The global menopausal hot flashes treatment industry is projected to reach more than US$ 11.5 Bn by the end of 2035

What are the factors driving the menopausal hot flashes treatment market?

The increasing global population of aging women, growing awareness about menopause and its symptoms, development of both hormonal and non-hormonal therapies and rising healthcare access are some of the factors driving the expansion of menopausal hot flashes treatment market.

What will be the CAGR of the global menopausal hot flashes treatment industry during the forecast period?

The CAGR is anticipated to be 4.8% from 2025 to 2035

Who are the prominent players in the global menopausal hot flashes treatment market?

Preface
- Market Definition and Scope
- Market Segmentation
- Key Research Objectives
- Research Highlights
Assumptions and Research Methodology
Executive Summary: Global Menopausal Hot Flashes Treatment Market
Market Overview
- Introduction
  - Segment Definition
- Overview
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- Global Menopausal Hot Flashes Treatment Market Analysis and Forecast, 2020 - 2035
  - Market Revenue Projections (US$ Bn)
Key Insights
- Healthcare Expenditure across Key Countries / Regions
- Recent Advancements in Menopausal Hot Flashes Treatment
- Pricing Trends for Menopausal Hot Flashes Treatment
- Regulatory Scenario across Key Regions / Countries
- PORTER’s Five Forces Analysis
- PESTLE Analysis
- Go-to-Market Strategy for New Market Entrants
5.8.Key Purchase Metrics for End-users
- Key Industry Events (Partnership, Collaborations, Product approvals, merger & acquisitions)
- Benchmarking of the Products Offered by the Leading Competitors
Global Menopausal Hot Flashes Treatment Market Analysis and Forecast, by Treatment Type
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Treatment Type, 2020 - 2035
  - Hormonal Treatment
    - Estrogen
    - Progesterone
    - Estrogen-progesterone Combination
  - Non-Hormonal Treatment
    - NK-3 Receptor Antagonists
    - Selective Serotonin Reuptake Inhibitors (SSRIs)
    - Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
    - Gabapentinoids
    - Others
- Market Attractiveness Analysis, by Treatment Type
Global Menopausal Hot Flashes Treatment Market Analysis and Forecast, by Drug Type
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Drug Type, 2020 - 2035
  - Branded
  - Generic
- Market Attractiveness Analysis, by Drug Type
Global Menopausal Hot Flashes Treatment Market Analysis and Forecast, by Route of Administration
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Route of Administration, 2020 - 2035
  - Oral
  - Transdermal
  - Vaginal
  - Parenteral
- Market Attractiveness Analysis, by Route of Administration
Global Menopausal Hot Flashes Treatment Market Analysis and Forecast, by Menopause Stage
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Menopause Stage, 2020 - 2035
  - Pre-menopause
  - Post-menopause
- Market Attractiveness Analysis, by Menopause Stage
Global Menopausal Hot Flashes Treatment Market Analysis and Forecast, by Distribution Channel
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Distribution Channel, 2020 - 2035
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Attractiveness Analysis, by Distribution Channel
Global Menopausal Hot Flashes Treatment Market Analysis and Forecast, by Region
- Key Findings
- Market Value Forecast, by Region, 2020 - 2035
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East & Africa
- Market Attractiveness Analysis, by Region
North America Menopausal Hot Flashes Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Treatment Type, 2020 - 2035
  - Hormonal Treatment
    - Estrogen
    - Progesterone
    - Estrogen-progesterone Combination
  - Non-Hormonal Treatment
    - NK-3 Receptor Antagonists
    - Selective Serotonin Reuptake Inhibitors (SSRIs)
    - Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
    - Gabapentinoids
    - Others
- Market Value Forecast, by Drug Type, 2020 - 2035
  - Branded
  - Generic
- Market Value Forecast, by Route of Administration, 2020 - 2035
  - Oral
  - Transdermal
  - Vaginal
  - Parenteral
- Market Value Forecast, by Menopause Stage, 2020 - 2035
  - Pre-menopause
  - Post-menopause
- Market Value Forecast, by Distribution Channel, 2020 - 2035
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Value Forecast, by Country, 2020 - 2035
  - U.S.
  - Canada
- Market Attractiveness Analysis
  - By Treatment Type
  - By Drug Type
  - By Route of Administration
  - By Menopause Stage
  - By Distribution Channel
  - By Country
Europe Menopausal Hot Flashes Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Treatment Type, 2020 - 2035
  - Hormonal Treatment
    - Estrogen
    - Progesterone
    - Estrogen-progesterone Combination
  - Non-Hormonal Treatment
    - NK-3 Receptor Antagonists
    - Selective Serotonin Reuptake Inhibitors (SSRIs)
    - Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
    - Gabapentinoids
    - Others
- Market Value Forecast, by Drug Type, 2020 - 2035
  - Branded
  - Generic
- Market Value Forecast, by Route of Administration, 2020 - 2035
  - Oral
  - Transdermal
  - Vaginal
  - Parenteral
- Market Value Forecast, by Menopause Stage, 2020 - 2035
  - Pre-menopause
  - Post-menopause
- Market Value Forecast, by Distribution Channel, 2020 - 2035
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Value Forecast, by Country/Sub-region, 2020 - 2035
  - UK
  - Germany
  - France
  - Italy
  - Spain
  - The Netherlands
  - Rest of Europe
- Market Attractiveness Analysis
  - By Treatment Type
  - By Drug Type
  - By Route of Administration
  - By Menopause Stage
  - By Distribution Channel
  - By Country/Sub-region
Asia Pacific Menopausal Hot Flashes Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Treatment Type, 2020 - 2035
  - Hormonal Treatment
    - Estrogen
    - Progesterone
    - Estrogen-progesterone Combination
  - Non-Hormonal Treatment
    - NK-3 Receptor Antagonists
    - Selective Serotonin Reuptake Inhibitors (SSRIs)
    - Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
    - Gabapentinoids
    - Others
- Market Value Forecast, by Drug Type, 2020 - 2035
  - Branded
  - Generic
- Market Value Forecast, by Route of Administration, 2020 - 2035
  - Oral
  - Transdermal
  - Vaginal
  - Parenteral
- Market Value Forecast, by Menopause Stage, 2020 - 2035
  - Pre-menopause
  - Post-menopause
- Market Value Forecast, by Distribution Channel, 2020 - 2035
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Value Forecast, by Country/Sub-region, 2020 - 2035
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Market Attractiveness Analysis
  - By Treatment Type
  - By Drug Type
  - By Route of Administration
  - By Menopause Stage
  - By Distribution Channel
  - By Country/Sub-region
Latin America Menopausal Hot Flashes Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Treatment Type, 2020 - 2035
  - Hormonal Treatment
    - Estrogen
    - Progesterone
    - Estrogen-progesterone Combination
  - Non-Hormonal Treatment
    - NK-3 Receptor Antagonists
    - Selective Serotonin Reuptake Inhibitors (SSRIs)
    - Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
    - Gabapentinoids
    - Others
- Market Value Forecast, by Drug Type, 2020 - 2035
  - Branded
  - Generic
- Market Value Forecast, by Route of Administration, 2020 - 2035
  - Oral
  - Transdermal
  - Vaginal
  - Parenteral
- Market Value Forecast, by Menopause Stage, 2020 - 2035
  - Pre-menopause
  - Post-menopause
- Market Value Forecast, by Distribution Channel, 2020 - 2035
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Value Forecast, by Country/Sub-region, 2020 - 2035
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
- Market Attractiveness Analysis
  - By Treatment Type
  - By Drug Type
  - By Route of Administration
  - By Menopause Stage
  - By Distribution Channel
  - By Country/Sub-region
Middle East & Africa Menopausal Hot Flashes Treatment Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Treatment Type, 2020 - 2035
  - Hormonal Treatment
    - Estrogen
    - Progesterone
    - Estrogen-progesterone Combination
  - Non-Hormonal Treatment
    - NK-3 Receptor Antagonists
    - Selective Serotonin Reuptake Inhibitors (SSRIs)
    - Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
    - Gabapentinoids
    - Others
- Market Value Forecast, by Drug Type, 2020 - 2035
  - Branded
  - Generic
- Market Value Forecast, by Route of Administration, 2020 - 2035
  - Oral
  - Transdermal
  - Vaginal
  - Parenteral
- Market Value Forecast, by Menopause Stage, 2020 - 2035
  - Pre-menopause
  - Post-menopause
- Market Value Forecast, by Distribution Channel, 2020 - 2035
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- Market Value Forecast, by Country/Sub-region, 2020 - 2035
  - GCC Countries
  - South Africa
  - Rest of Middle East & Africa
- Market Attractiveness Analysis
  - By Treatment Type
  - By Drug Type
  - By Route of Administration
  - By Menopause Stage
  - By Distribution Channel
  - By Country/Sub-region
Competition Landscape
- Market Player - Competition Matrix (By Tier and Size of Companies)
- Market Share Analysis, by Company (2024)
- Company Profiles
  - Bayer AG
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments
  - Astellas Pharma Inc.
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments
  - Pfizer Inc.
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments
  - Novartis AG
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments
  - Merck & Co., Inc.
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments
  - Eli Lilly and Company
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments
  - Hisamitsu Pharmaceutical Co., Inc.
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments
  - TherapeuticsMD, Inc.
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments
  - Lupin
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments
  - GSK plc.
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments
  - Theramex
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments
  - Fervent Pharmaceuticals Inc.
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments
  - AbbVie Inc.
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments
  - Gennev
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments
  - Teva Pharmaceutical Industries Ltd.
    - Company Overview
    - Financial Overview
    - Financial Overview
    - Business Strategies
    - Recent Developments

List of Tables

Table 01: Global Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Treatment Type, 2020 to 2035
Table 02: Global Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Hormonal Treatment, 2020 to 2035
Table 03: Global Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Non-Hormonal Treatment, 2020 to 2035
Table 04: Global Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020 to 2035
Table 05: Global Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035
Table 06: Global Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Menopause Stage, 2020 to 2035
Table 07: Global Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
Table 08: Global Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Region, 2020 to 2035
Table 09: North America Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, by Country, 2020-2035
Table 10: North America Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Treatment Type, 2020 to 2035
Table 11: North America Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Hormonal Treatment, 2020 to 2035
Table 12: North America Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Non-Hormonal Treatment, 2020 to 2035
Table 13: North America Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020 to 2035
Table 14: North America Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035
Table 15: North America Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Menopause Stage, 2020 to 2035
Table 16: North America Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
Table 17: Europe Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, by Country, 2020-2035
Table 18: Europe Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Treatment Type, 2020 to 2035
Table 19: Europe Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Hormonal Treatment, 2020 to 2035
Table 20: Europe Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Non-Hormonal Treatment, 2020 to 2035
Table 21: Europe Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020 to 2035
Table 22: Europe Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035
Table 23: Europe Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Menopause Stage, 2020 to 2035
Table 24: Europe Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
Table 25: Asia Pacific Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, by Country, 2020-2035
Table 26: Asia Pacific Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Treatment Type, 2020 to 2035
Table 27: Asia Pacific Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Hormonal Treatment, 2020 to 2035
Table 28: Asia Pacific Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Non-Hormonal Treatment, 2020 to 2035
Table 29: Asia Pacific Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020 to 2035
Table 30: Asia Pacific Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035
Table 31: Asia Pacific Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Menopause Stage, 2020 to 2035
Table 32: Asia Pacific Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
Table 33: Latin America Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, by Country, 2020-2035
Table 34: Latin America Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Treatment Type, 2020 to 2035
Table 35: Latin America Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Hormonal Treatment, 2020 to 2035
Table 36: Latin America Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Non-Hormonal Treatment, 2020 to 2035
Table 37: Latin America Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020 to 2035
Table 38: Latin America Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035
Table 39: Latin America Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Menopause Stage, 2020 to 2035
Table 40: Latin America Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
Table 41: Middle East & Africa Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, by Country, 2020-2035
Table 42: Middle East & Africa Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Treatment Type, 2020 to 2035
Table 43: Middle East & Africa Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Hormonal Treatment, 2020 to 2035
Table 44: Middle East & Africa Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Non-Hormonal Treatment, 2020 to 2035
Table 45: Middle East & Africa Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020 to 2035
Table 46: Middle East & Africa Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035
Table 47: Middle East & Africa Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Menopause Stage, 2020 to 2035
Table 48: Middle East & Africa Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035

List of Figures

Figure 01: Global Menopausal Hot Flashes Treatment Market Value Share Analysis, By Treatment Type, 2024 and 2035
Figure 02: Global Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Treatment Type, 2025 to 2035
Figure 03: Global Menopausal Hot Flashes Treatment Market Revenue (US$ Bn), by Hormonal Treatment, 2020 to 2035
Figure 04: Global Menopausal Hot Flashes Treatment Market Revenue (US$ Bn), by Non-Hormonal Treatment, 2020 to 2035
Figure 05: Global Menopausal Hot Flashes Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
Figure 06: Global Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Drug Type, 2025 to 2035
Figure 07: Global Menopausal Hot Flashes Treatment Market Revenue (US$ Bn), by Branded, 2020 to 2035
Figure 08: Global Menopausal Hot Flashes Treatment Market Revenue (US$ Bn), by Generic, 2020 to 2035
Figure 09: Global Menopausal Hot Flashes Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
Figure 10: Global Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Route of Administration, 2025 to 2035
Figure 11: Global Menopausal Hot Flashes Treatment Market Revenue (US$ Bn), by Oral, 2020 to 2035
Figure 12: Global Menopausal Hot Flashes Treatment Market Revenue (US$ Bn), by Transdermal, 2020 to 2035
Figure 13: Global Menopausal Hot Flashes Treatment Market Revenue (US$ Bn), by Vaginal, 2020 to 2035
Figure 14: Global Menopausal Hot Flashes Treatment Market Revenue (US$ Bn), by Parenteral, 2020 to 2035\
Figure 15: Global Menopausal Hot Flashes Treatment Market Value Share Analysis, By Menopause Stage, 2024 and 2035
Figure 16: Global Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Menopause Stage, 2025 to 2035
Figure 17: Global Menopausal Hot Flashes Treatment Market Revenue (US$ Bn), by Pre-menopause, 2020 to 2035
Figure 18: Global Menopausal Hot Flashes Treatment Market Revenue (US$ Bn), by Post-menopause, 2020 to 2035
Figure 19: Global Menopausal Hot Flashes Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
Figure 20: Global Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
Figure 21: Global Menopausal Hot Flashes Treatment Market Revenue (US$ Bn), by Hospital Pharmacies, 2020 to 2035
Figure 22: Global Menopausal Hot Flashes Treatment Market Revenue (US$ Bn), by Retail Pharmacies, 2020 to 2035
Figure 23: Global Menopausal Hot Flashes Treatment Market Revenue (US$ Bn), by Online Pharmacies, 2020 to 2035
Figure 24: Global Menopausal Hot Flashes Treatment Market Value Share Analysis, By Region, 2024 and 2035
Figure 25: Global Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Region, 2025 to 2035
Figure 26: North America Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 27: North America Menopausal Hot Flashes Treatment Market Value Share Analysis, by Country, 2024 and 2035
Figure 28: North America Menopausal Hot Flashes Treatment Market Attractiveness Analysis, by Country, 2025 to 2035
Figure 29: North America Menopausal Hot Flashes Treatment Market Value Share Analysis, By Treatment Type, 2024 and 2035
Figure 30: North America Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Treatment Type, 2025 to 2035
Figure 31: North America Menopausal Hot Flashes Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
Figure 32: North America Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Drug Type, 2025 to 2035
Figure 33: North America Menopausal Hot Flashes Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
Figure 34: North America Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Route of Administration, 2025 to 2035
Figure 35: North America Menopausal Hot Flashes Treatment Market Value Share Analysis, By Menopause Stage, 2024 and 2035
Figure 36: North America Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Menopause Stage, 2025 to 2035
Figure 37: North America Menopausal Hot Flashes Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
Figure 38: North America Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
Figure 39: Europe Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 40: Europe Menopausal Hot Flashes Treatment Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 41: Europe Menopausal Hot Flashes Treatment Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
Figure 42: Europe Menopausal Hot Flashes Treatment Market Value Share Analysis, By Treatment Type, 2024 and 2035
Figure 43: Europe Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Treatment Type, 2025 to 2035
Figure 44: Europe Menopausal Hot Flashes Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
Figure 45: Europe Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Drug Type, 2025 to 2035
Figure 46: Europe Menopausal Hot Flashes Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
Figure 47: Europe Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Route of Administration, 2025 to 2035
Figure 48: Europe Menopausal Hot Flashes Treatment Market Value Share Analysis, By Menopause Stage, 2024 and 2035
Figure 49: Europe Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Menopause Stage, 2025 to 2035
Figure 50: Europe Menopausal Hot Flashes Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
Figure 51: Europe Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
Figure 52: Asia Pacific Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 53: Asia Pacific Menopausal Hot Flashes Treatment Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 54: Asia Pacific Menopausal Hot Flashes Treatment Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
Figure 55: Asia Pacific Menopausal Hot Flashes Treatment Market Value Share Analysis, By Treatment Type, 2024 and 2035
Figure 56: Asia Pacific Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Treatment Type, 2025 to 2035
Figure 57: Asia Pacific Menopausal Hot Flashes Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
Figure 58: Asia Pacific Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Drug Type, 2025 to 2035
Figure 59: Asia Pacific Menopausal Hot Flashes Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
Figure 60: Asia Pacific Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Route of Administration, 2025 to 2035
Figure 61: Asia Pacific Menopausal Hot Flashes Treatment Market Value Share Analysis, By Menopause Stage, 2024 and 2035
Figure 62: Asia Pacific Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Menopause Stage, 2025 to 2035
Figure 63: Asia Pacific Menopausal Hot Flashes Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
Figure 64: Asia Pacific Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
Figure 65: Latin America Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 66: Latin America Menopausal Hot Flashes Treatment Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 67: Latin America Menopausal Hot Flashes Treatment Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
Figure 68: Latin America Menopausal Hot Flashes Treatment Market Value Share Analysis, By Treatment Type, 2024 and 2035
Figure 69: Latin America Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Treatment Type, 2025 to 2035
Figure 70: Latin America Menopausal Hot Flashes Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
Figure 71: Latin America Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Drug Type, 2025 to 2035
Figure 72: Latin America Menopausal Hot Flashes Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
Figure 73: Latin America Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Route of Administration, 2025 to 2035
Figure 74: Latin America Menopausal Hot Flashes Treatment Market Value Share Analysis, By Menopause Stage, 2024 and 2035
Figure 75: Latin America Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Menopause Stage, 2025 to 2035
Figure 76: Latin America Menopausal Hot Flashes Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
Figure 77: Latin America Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
Figure 78: Middle East & Africa Menopausal Hot Flashes Treatment Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 79: Middle East & Africa Menopausal Hot Flashes Treatment Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 80: Middle East & Africa Menopausal Hot Flashes Treatment Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
Figure 81: Middle East & Africa Menopausal Hot Flashes Treatment Market Value Share Analysis, By Treatment Type, 2024 and 2035
Figure 82: Middle East & Africa Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Treatment Type, 2025 to 2035
Figure 83: Middle East & Africa Menopausal Hot Flashes Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
Figure 84: Middle East & Africa Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Drug Type, 2025 to 2035
Figure 85: Middle East & Africa Menopausal Hot Flashes Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
Figure 86: Middle East & Africa Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Route of Administration, 2025 to 2035
Figure 87: Middle East & Africa Menopausal Hot Flashes Treatment Market Value Share Analysis, By Menopause Stage, 2024 and 2035
Figure 88: Middle East & Africa Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Menopause Stage, 2025 to 2035
Figure 89: Middle East & Africa Menopausal Hot Flashes Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
Figure 90: Middle East & Africa Menopausal Hot Flashes Treatment Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035